当前位置:首页 - 行情中心 - 小方制药(603207) - 财务分析 - 资产负债表

小方制药

(603207)

  

流通市值:10.58亿  总市值:43.18亿
流通股本:3919.78万   总股本:1.60亿

资产负债表

报告期2024-09-302024-06-302023-12-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金852,014,375.21346,083,915.84285,544,032.858,662,660.33
应收票据及应收账款95,690,798.19115,788,351.1785,390,872.8181,875,443.53
其中:应收票据500,000---
应收账款95,190,798.19115,788,351.1785,390,872.8181,875,443.53
预付款项7,490,535.467,066,205.2410,723,299.3911,016,695.43
其他应收款合计663,259.88599,880.37644,959.46247,532.27
存货41,566,870.3440,574,244.9249,902,888.5357,202,248.47
一年内到期的非流动资产---1,305,047.79
其他流动资产1,359,059.3215,293,825.6916,882,795.018,594,647.56
流动资产平衡项目0000
流动资产合计998,784,898.4525,406,423.23452,062,918.8327,867,061.92
非流动资产:
固定资产8,389,344.38,560,705.649,228,003.0711,713,575.85
在建工程312,681,593269,034,490.72216,530,386.5350,040,052.39
使用权资产504,926.42605,911.69807,882.251,211,823.36
无形资产24,926,267.2825,323,164.6726,116,959.4527,704,549.01
长期待摊费用1,381,826.821,201,473.64470,218.33485,638.43
递延所得税资产3,275,480.42,494,544.712,855,746.72,272,274.16
其他非流动资产1,391,4259,239,067.54,578,830.9942,003,995.5
非流动资产平衡项目0000
非流动资产合计352,550,863.22316,459,358.57260,588,027.32135,431,908.7
资产平衡项目0000
资产总计1,351,335,761.62841,865,781.8712,650,946.12463,298,970.62
流动负债:
应付票据及应付账款24,209,488.1120,522,375.9419,612,981.0627,422,811.61
应付账款24,209,488.1120,522,375.9419,612,981.0627,422,811.61
合同负债501,807.36598,571.88610,608.611,545,711.39
应付职工薪酬5,985,192.625,630,639.916,755,252.287,427,937.78
应交税费10,114,230.5813,167,438.445,764,005.5316,522,747.15
其他应付款合计116,983,342.34100,434,019.7597,211,960.1135,237,328.62
一年内到期的非流动负债549,672.44657,129.85422,218.5384,794.8
其他流动负债2,375,903.131,393,939.391,799,224.31,421,371.84
流动负债平衡项目0000
流动负债合计160,719,636.58142,404,115.16132,176,250.3989,962,703.19
非流动负债:
租赁负债112,499.99223,702.36442,273.86882,770.11
递延收益68,571.3671,785.6578,214.2391,071.39
非流动负债平衡项目0000
非流动负债合计181,071.35295,488.01520,488.09973,841.5
负债平衡项目0000
负债合计160,900,707.93142,699,603.17132,696,738.4890,936,544.69
所有者权益(或股东权益):
实收资本(或股本)160,000,000120,000,000120,000,000120,000,000
资本公积478,030,960.4569,615,641.8769,219,601.7165,254,847.66
盈余公积42,617,733.8542,617,733.8542,617,733.8522,260,434.54
未分配利润509,786,359.39466,932,802.91348,116,872.08164,847,143.73
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,190,435,053.69699,166,178.63579,954,207.64372,362,425.93
股东权益平衡项目0000
股东权益合计1,190,435,053.69699,166,178.63579,954,207.64372,362,425.93
负债和股东权益合计1,351,335,761.62841,865,781.8712,650,946.12463,298,970.62
公告日期2024-10-292024-08-072024-08-072023-07-06
审计意见(境内)标准无保留意见标准无保留意见
TOP↑